Get 40% Off
👀 Reveal Warren Buffet's stock picks that are beating the S&P 500 by +174.3% Get 40% Off

Tempest Therapeutics Inc (TPST)

NASDAQ
Currency in USD
Disclaimer
3.9400
-0.0200(-0.51%)
Closed
Pre Market
3.94000.0000(0.00%)
Day's Range
3.91004.0434
52 wk Range
0.17009.7700
Prev. Close
3.96
Open
3.96
Day's Range
3.91-4.0434
52 wk Range
0.17-9.77
Volume
361,631
Average Vol. (3m)
945,476
1-Year Change
135.93%
Shares Outstanding
19,247,495
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
20.0000
Upside +407.6142%

People Also Watch

0.1735
SPCB
-0.86%
1.85
HTOO
-3.14%
1.020
ENTX
-2.86%
851.11
SMCI
-2.88%
How do you feel today about TPST?
Vote to see community's results!
or

Tempest Therapeutics Inc Company Profile

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company’s two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.